Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Impact BioMedical, Inc. ( (IBO) ) has shared an update.
On October 30, 2023, Impact BioMedical, Inc. announced that DSS BioHealth Security, Inc. has converted its Series A Convertible Preferred Stock into 60,496,041 shares of common stock. This conversion could potentially impact the company’s market operations by increasing the number of common shares available, which may influence shareholder value and market perception.
More about Impact BioMedical, Inc.
Average Trading Volume: 219,531
Technical Sentiment Signal: Strong Sell
Find detailed analytics on IBO stock on TipRanks’ Stock Analysis page.